UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000062072 |
|---|---|
| Receipt number | R000071005 |
| Scientific Title | Functional effects of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) intake on maintaining and improving skin function in healthy adults: a systematic review |
| Date of disclosure of the study information | 2026/06/26 |
| Last modified on | 2026/06/25 16:21:30 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Functional effects of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) intake on maintaining and improving skin function in healthy adults: a systematic review
Acronym
Functional effects of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) intake on maintaining and improving skin function in healthy adults: a systematic review
Scientific Title
Functional effects of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) intake on maintaining and improving skin function in healthy adults: a systematic review
Scientific Title:Acronym
Functional effects of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) intake on maintaining and improving skin function in healthy adults: a systematic review
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate whether oral intake of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) contributes to maintaining and improving skin function in healthy adults.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
maintaining and improving skin function
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
P (Participant) : Healthy adults
I (Intervention) : Oral intake of foods containing royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid)
C (Comparison) : Oral intake of placebo foods
O (Outcome) : Evaluation of the effects on maintaining and improving skin function
S (Study Design) : Parallel-group or crossover randomized controlled trials
Key exclusion criteria
Studies that do not match the PICOS criteria
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Toshiharu |
| Middle name | |
| Last name | Miyai |
Organization
Yamada Bee Company, Inc.
Division name
Dietary Supplement Development Section
Zip code
708-0393
Address
194 Ichiba, Kagamino-cho, Tomata-gun, Okayama, 708-0393, Japan
TEL
0868-54-5138
tm1614@yamada-bee.com
Public contact
Name of contact person
| 1st name | Mari |
| Middle name | |
| Last name | Deguchi |
Organization
Yamada Bee Company, Inc.
Division name
Service Development Section, R&D Department
Zip code
708-0393
Address
194 Ichiba, Kagamino-cho, Tomata-gun, Okayama, 708-0393, Japan
TEL
0868-54-0055
Homepage URL
md2175@yamada-bee.com
Sponsor or person
Institute
Yamada Bee Company, Inc.
Institute
Department
Personal name
Funding Source
Organization
Yamada Bee Company, Inc.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Not applicable
Address
Not applicable
Tel
0868-54-0055
md2175@yamada-bee.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 06 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 06 | Month | 25 | Day |
Date of IRB
Anticipated trial start date
| 2026 | Year | 06 | Month | 29 | Day |
Last follow-up date
| 2026 | Year | 08 | Month | 29 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This research review will be conducted in accordance with PRISMA 2020
Management information
Registered date
| 2026 | Year | 06 | Month | 26 | Day |
Last modified on
| 2026 | Year | 06 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000071005
